Migraine vertigo study pulled before start: drug vs lifestyle showdown never happened
NCT ID NCT06417684
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to see whether the drug amitriptyline or lifestyle changes work better for people with vestibular migraine, a condition that causes dizziness and headache. The plan was to randomly assign adults with definite vestibular migraine to one of the two treatments and track their symptoms for up to a year. However, the study was withdrawn before enrolling any participants, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VESTIBULAR MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Wearable eye-tracker aims to catch dizziness in the act
- Can a new migraine drug stop the dizzy spells?
- Ringing relief? migraine drugs tested for tinnitus in new study
- New wearable device aims to diagnose dizziness causes automatically
- New tool could help teens with dizzying migraines get better care
- Scientists hunt for genetic clues to Menière's disease